Accent Capital Management, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 2014179
CENTERVILLE, OH
Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$16,916
New position
Shares Held
138
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#292
of 341 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Accent Capital Management, LLC holds $1,172,462 across 18 Biotechnology names. PTGX ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,049 | $973,230 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
351 | $40,249 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
748 | $18,146 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
This page
|
138 | $16,916 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
50 | $16,739 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
31 | $16,645 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
107 | $11,880 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
214 | $11,757 |
All Filings in PTGX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,916 | 138 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||